Another Magic Cure from cancer. Post No 21. Paclitaxel?

FDA approved an sNDA from Celgene Corp. (NASDAQ:CELG) for Abraxane nab-paclitaxel for first-line treatment of advanced non-small cell lung cancer (NSCLC). The albumin stabilized nanoparticle formulation of paclitaxel was first approved in the U.S. in 2005

And what is important that Abraxane is just a novel formulation of well known effective and NON-TARGETED drug paclitaxel.

It works well against ALL cancer mutations and variants. That's it... First line treatment... Any ideas regarding targeted approach?